Lluis Pages-Ballell

Tres Cantos, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A three-dimensional high throughput assay identifies novel antibacterial molecules with activity against intracellular Shigella.

A three-dimensional high throughput assay identifies novel antibacterial molecules with activity against intracellular Shigella.

Journal: npj antimicrobials and resistance

Published: January 21, 2025

The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp.

The repurposing of Tebipenem pivoxil as alternative therapy for severe gastrointestinal infections caused by extensively drug-resistant Shigella spp.

Journal: eLife

Published: April 27, 2021

Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent.

Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent.

Journal: PloS one

Published: February 15, 2017

N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity.

N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity.

Journal: ChemMedChem

Published: January 11, 2016

New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold.

New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold.

Journal: European journal of medicinal chemistry

Published: December 21, 2015

Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials.

Carbamoyl Triazoles, Known Serine Protease Inhibitors, Are a Potent New Class of Antimalarials.

Journal: Journal of medicinal chemistry

Published: July 30, 2015

A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: N-[3-[(Benzimidazol-2-yl)amino]propyl]amides.

A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: N-[3-[(Benzimidazol-2-yl)amino]propyl]amides.

Journal: Journal of medicinal chemistry

Published: April 24, 2015

Design, synthesis, and evaluation of new thiadiazole-based direct inhibitors of enoyl acyl carrier protein reductase (InhA) for the treatment of tuberculosis.

Design, synthesis, and evaluation of new thiadiazole-based direct inhibitors of enoyl acyl carrier protein reductase (InhA) for the treatment of tuberculosis.

Journal: Journal of medicinal chemistry

Published: December 18, 2014

Testing tuberculosis drug efficacy in a zebrafish high-throughput translational medicine screen.

Testing tuberculosis drug efficacy in a zebrafish high-throughput translational medicine screen.

Journal: Antimicrobial agents and chemotherapy

Published: November 12, 2014

High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis.

High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: October 29, 2014

Encoded library technology as a source of hits for the discovery and lead optimization of a potent and selective class of bactericidal direct inhibitors of Mycobacterium tuberculosis InhA.

Encoded library technology as a source of hits for the discovery and lead optimization of a potent and selective class of bactericidal direct inhibitors of Mycobacterium tuberculosis InhA.

Journal: Journal of medicinal chemistry

Published: January 24, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026